IL-7Rα Deficiency in P53null Mice Exacerbates Thymocyte Telomere Erosion and Lymphomagenesis

Overview

Journal Cell Death Differ

Specialty Cell Biology

Date 2012 Jan 28

PMID 22281704

Citations 12

Authors

R Kibe

S Zhang

D Guo

L Marrero

F Tsien

P Rodriguez

S Khan

A Zieske

J Huang

W Li

S K Durum

T Iwakuma

Y Cui

Affiliations

Soon will be listed here.

Abstract

Interleukin-7 (IL-7) is an essential T-cell survival cytokine. IL-7 receptor (IL-7Rα) deficiency severely impairs T-cell development due to substantial apoptosis. We hypothesized that IL-7Rα(null)-induced apoptosis is partially contributed by an elevated p53 activity. To investigate the genetic association of IL-7/IL-7Rα signaling with the p53 pathway, we generated IL-7Rα(null)p53(null) (DKO) mice. DKO mice exhibited a marked reduction of apoptosis in developing T cells and an augmented thymic lymphomagenesis with telomere erosions and exacerbated chromosomal anomalies, including chromosome duplications, breaks, and translocations. In particular, Robertsonian translocations, in which telocentric chromosomes fuse at the centromeric region, and a complete loss of telomeres at the fusion site occurred frequently in DKO thymic lymphomas. Cellular and molecular investigations revealed that IL-7/IL-7Rα signaling withdrawal diminished the protein synthesis of protection of telomere 1 (POT1), a subunit of telomere protective complex shelterin, leading to telomere erosion and the activation of the p53 pathway. Blockade of IL-7/IL-7Rα signaling in IL-7-dependent p53(null) cells reduced POT1 expression and caused telomere and chromosome abnormalities similar to those observed in DKO lymphomas. This study underscores a novel function of IL-7/IL-7Rα during T-cell development in regulating telomere integrity via POT1 expression and provides new insights into cytokine-mediated survival signals and T-cell lymphomagenesis.

Citing Articles

Lung transplant recipients with idiopathic pulmonary fibrosis have impaired alloreactive immune responses.

Wang P, Leung J, Lam A, Lee S, Calabrese D, Hays S J Heart Lung Transplant. 2021; 41(5):641-653.

PMID: 34924263 PMC: 9038662. DOI: 10.1016/j.healun.2021.11.012.

Flip the coin: IL-7 and IL-7R in health and disease.

Barata J, Durum S, Seddon B Nat Immunol. 2019; 20(12):1584-1593.

PMID: 31745336 DOI: 10.1038/s41590-019-0479-x.

IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update.

Oliveira M, Akkapeddi P, Ribeiro D, Melao A, Barata J Adv Biol Regul. 2018; 71:88-96.

PMID: 30249539 PMC: 6386770. DOI: 10.1016/j.jbior.2018.09.012.

Human thymus medullary epithelial cells promote regulatory T-cell generation by stimulating interleukin-2 production via ICOS ligand.

Nazzal D, Gradolatto A, Truffault F, Bismuth J, Berrih-Aknin S Cell Death Dis. 2014; 5:e1420.

PMID: 25210803 PMC: 4540205. DOI: 10.1038/cddis.2014.377.

Ribosomal protein S27-like is a physiological regulator of p53 that suppresses genomic instability and tumorigenesis.

Xiong X, Zhao Y, Tang F, Wei D, Thomas D, Wang X Elife. 2014; 3:e02236.

PMID: 25144937 PMC: 4163686. DOI: 10.7554/eLife.02236.

References

Takai H, Smogorzewska A, de Lange T . DNA damage foci at dysfunctional telomeres. Curr Biol. 2003; 13(17):1549-56. DOI: 10.1016/s0960-9822(03)00542-6. View

Kim K, Khaled A, Reynolds D, Young H, Lee C, Durum S . Characterization of an interleukin-7-dependent thymic cell line derived from a p53(-/-) mouse. J Immunol Methods. 2003; 274(1-2):177-84. DOI: 10.1016/s0022-1759(02)00513-6. View

Levine A, Oren M . The first 30 years of p53: growing ever more complex. Nat Rev Cancer. 2009; 9(10):749-58. PMC: 2771725. DOI: 10.1038/nrc2723. View

Green D, Schuler M . T cell development: some cells get all the breaks. Nat Immunol. 2001; 1(1):15-7. DOI: 10.1038/76868. View

Maraskovsky E, OReilly L, Teepe M, Corcoran L, Peschon J, Strasser A . Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/- mice. Cell. 1997; 89(7):1011-9. DOI: 10.1016/s0092-8674(00)80289-5. View

Chin L, Artandi S, Shen Q, Tam A, Lee S, Gottlieb G . p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell. 1999; 97(4):527-38. DOI: 10.1016/s0092-8674(00)80762-x. View

Zenatti P, Ribeiro D, Li W, Zuurbier L, Silva M, Paganin M . Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia. Nat Genet. 2011; 43(10):932-9. PMC: 7424552. DOI: 10.1038/ng.924. View

Michalak E, Vandenberg C, Delbridge A, Wu L, Scott C, Adams J . Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death. Genes Dev. 2010; 24(15):1608-13. PMC: 2912558. DOI: 10.1101/gad.1940110. View

Williams E, Klingler R, Ponnaiya B, Hardt T, Schrock E, Lees-Miller S . Telomere dysfunction and DNA-PKcs deficiency: characterization and consequence. Cancer Res. 2009; 69(5):2100-7. PMC: 3595006. DOI: 10.1158/0008-5472.CAN-08-2854. View

10.

Jacks T, Remington L, Williams B, Schmitt E, Halachmi S, Bronson R . Tumor spectrum analysis in p53-mutant mice. Curr Biol. 1994; 4(1):1-7. DOI: 10.1016/s0960-9822(00)00002-6. View

11.

Zhang S, Zheng M, Kibe R, Huang Y, Marrero L, Warren S . Trp53 negatively regulates autoimmunity via the STAT3-Th17 axis. FASEB J. 2011; 25(7):2387-98. PMC: 3114529. DOI: 10.1096/fj.10-175299. View

12.

Mak T, Hakem A, McPherson J, Shehabeldin A, Zablocki E, Migon E . Brca1 required for T cell lineage development but not TCR loci rearrangement. Nat Immunol. 2001; 1(1):77-82. DOI: 10.1038/76950. View

13.

Levine A . p53, the cellular gatekeeper for growth and division. Cell. 1997; 88(3):323-31. DOI: 10.1016/s0092-8674(00)81871-1. View

14.

Peschon J, Morrissey P, Grabstein K, Ramsdell F, Maraskovsky E, Gliniak B . Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med. 1994; 180(5):1955-60. PMC: 2191751. DOI: 10.1084/jem.180.5.1955. View

15.

Martinez P, Blasco M . Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer. 2011; 11(3):161-76. DOI: 10.1038/nrc3025. View

16.

Hockemeyer D, Daniels J, Takai H, de Lange T . Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres. Cell. 2006; 126(1):63-77. DOI: 10.1016/j.cell.2006.04.044. View

17.

Davoli T, Denchi E, de Lange T . Persistent telomere damage induces bypass of mitosis and tetraploidy. Cell. 2010; 141(1):81-93. PMC: 2854042. DOI: 10.1016/j.cell.2010.01.031. View

18.

Thanasoula M, Escandell J, Martinez P, Badie S, Munoz P, Blasco M . p53 prevents entry into mitosis with uncapped telomeres. Curr Biol. 2010; 20(6):521-6. PMC: 4959573. DOI: 10.1016/j.cub.2010.01.046. View

19.

Baumann P, Cech T . Pot1, the putative telomere end-binding protein in fission yeast and humans. Science. 2001; 292(5519):1171-5. DOI: 10.1126/science.1060036. View

20.

Haines B, Ryu C, Chang S, Protopopov A, Luch A, Kang Y . Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterations. Cancer Cell. 2006; 9(2):109-20. DOI: 10.1016/j.ccr.2006.01.004. View